Spectral AI Inc. Class A (MDAI)
NASDAQ: MDAIHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MDAI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $33.47M
- EPS (TTM)
- -$0.30
- Dividend yield
- None
- 52-week range
- 1.00 – 2.97
- Day range
- 1.00 – 1.28
- Volume / Avg
- 944.28K / 142.00K
- Beta
- —
- Shares outstanding
- 32.18M
52-week range
MDAI stock today
On Nov 20, MDAI ended the session at $1.04, shedding $0.27 (20.61%), versus the S&P 500's 3.70% decline. Volume was 6.7x the average at 944.28K shares, a sign of unusually heavy trading. Shares are 65.0% below their 52-week high of $2.97, set on May 26, 2026 and 4.0% above the 52-week low of $1.00, near the bottom of the past year's range.
MDAI is down 26.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 27.3%. Spectral AI has posted a net loss over the last twelve months (EPS of -$0.30), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Spectral AI
Company profileSpectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Vincent Stanley Capone Esq.
- Headquarters
- Dallas, TX
- Employees
- 65
- IPO year
- 2021
- Website
- spectral-ai.com
Financial highlights
Full financialsIn fiscal 2025, Spectral AI generated $19.6 million in revenue, down 33.6% from fiscal 2024, its first annual decline since 2023. Spectral AI reported a net loss of $7.6 million, compared with a loss of $15.2 million a year earlier. Gross margin was 45.4% (up from 44.9%) and operating margin -43.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $19.65M | $29.58M | $18.06M | $25.37M | — |
| Growth | -33.57% | +63.83% | -28.82% | — | — |
| Net income | $-7.57M | $-15.16M | $-20.85M | $-2.91M | $-2.15M |
| EPS (diluted) | $-0.29 | $-0.85 | $-1.48 | $-0.22 | — |
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$5.11+391.35%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $-0.13 vs $-0.14
- Surprise
- +7.14%
MDAI news
All MDAI news- Spectral AI: 3 Key Takeaways for Long-Term InvestorsNasdaqMDAI, LEN.B
- Spectral AI, Inc. Enters into $15.0 million Standby Equity Purchase AgreementNasdaq
- Spectral AI Announces 2026 Third Quarter Financial ResultsGlobeNewswire
- Spectral AI’s DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific AssemblyGlobeNewswire
Spectral AI peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TELATELA Bio Inc. | 0.6885 | -5.27% | $31.11M | vs MDAI |
| SRTSSensus Healthcare Inc. | 2.26 | -4.24% | $37.20M | vs MDAI |
| XTNTXtant Medical Holdings Inc. | 0.21 | -2.82% | $29.49M | vs MDAI |
| NSPRInspireMD Inc. | 0.54 | -12.97% | $29.23M | vs MDAI |
| NEPHNephros Inc. | 2.61 | -8.10% | $28.37M | vs MDAI |
| DXRDaxor Corporation | 7.45 | -7.33% | $43.49M | vs MDAI |
| PLRZPolyrizon Ltd. | 9.31 | -8.42% | $22.61M | vs MDAI |
| DAVIDavion Healthcare Plc | 0.9001 | -9.99% | $22.50M | vs MDAI |
Indexes, lists and sector
Spectral AI stock FAQ
What is Spectral AI's stock price today?
MDAI last traded at $1.04 as of Nov 20, 4:00 PM EST, down 20.61% on the day. Prices are delayed at least 15 minutes.
Who is Spectral AI's CEO?
Mr. Vincent Stanley Capone Esq. is the chief executive officer of Spectral AI Inc. Class A, which has about 65 employees.
What is the MDAI 52-week high?
The 52-week high for MDAI is $2.97 and the 52-week low is $1.00. The stock is currently 65.0% below its high.